Covid-19-induced coagulopathy and observed benefits with anticoagulation

Transfus Apher Sci. 2020 Dec;59(6):102906. doi: 10.1016/j.transci.2020.102906. Epub 2020 Aug 3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anticoagulants / therapeutic use*
  • Blood Coagulation Disorders / etiology*
  • Blood Coagulation Disorders / virology*
  • COVID-19 / complications*
  • Fibrin Fibrinogen Degradation Products / metabolism
  • Hospitalization
  • Humans
  • Practice Guidelines as Topic
  • SARS-CoV-2 / physiology*
  • Thrombosis / etiology
  • Thrombosis / virology

Substances

  • Anticoagulants
  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D